Mounedji-Boudiaf L, Rougier P, Culine S, de Baere T, Lasser P, Escudier B, Ducreux M, Kaloustian E, Droz J P, Roche A
Département de Médecine, Institut Gustave Roussy, Villejuif.
Presse Med. 1995 May 27;24(19):894-6.
Malignant insulinomas are slow growing tumours for which the prognosis is worsened by metastatic disease and sequellae of excess hormone secretion. Management of unresectable tumours includes intravenous chemotherapy and local treatments such as palliative surgery and transcatheter arterial embolization of liver metastases. Long-term survival can also be improved by inhibition of secretory products of the tumour with either octreotide, a somatostatin analogue, or diazoxide. We report two cases of malignant insulinomas with liver metastases for which objective responses were obtained with combination of local treatment and intravenous chemotherapy.
恶性胰岛素瘤生长缓慢,转移性疾病和激素分泌过多的后遗症会使预后恶化。不可切除肿瘤的治疗方法包括静脉化疗和局部治疗,如姑息性手术和肝转移瘤的经导管动脉栓塞术。使用生长抑素类似物奥曲肽或二氮嗪抑制肿瘤分泌产物也可提高长期生存率。我们报告了两例伴有肝转移的恶性胰岛素瘤病例,通过局部治疗和静脉化疗相结合获得了客观缓解。